# University of Portland

**Type:** Institutions  
**Canonical URL:** https://scholariq.org/institutions/university-of-portland/

## Facts

| Field | Value |
| --- | --- |
| Avg h-index | 49 |
| Citations | 267,955 |
| City | Portland |
| Country | US |
| Description | University of Portland is a research organisation in Portland, US. OpenAlex records 7,349 works and 267,955 citations for it. 1,944 researchers list it as their most recent affiliation. |
| Homepage | http://www.up.edu/ |
| OpenAlex ID | https://openalex.org/I71578702 |
| Researchers | 1,944 |
| ROR ID | https://ror.org/01q6pmm96 |
| Type | education |
| Wikidata ID | https://www.wikidata.org/wiki/Q513658 |
| Works | 7,349 |

## University papers

- [Tolvaptan in Patients with Autosomal Dominant Polycystic Kidney Disease](https://scholariq.org/papers/tolvaptan-in-patients-with-autosomal-dominant-polycystic-kidney-disease/)
- [Tolvaptan, a Selective Oral Vasopressin V <sub>2</sub> -Receptor Antagonist, for Hyponatremia](https://scholariq.org/papers/tolvaptan-a-selective-oral-vasopressin-v-sub-2-sub-receptor-antagonist-for/)
- [Tolvaptan in Later-Stage Autosomal Dominant Polycystic Kidney Disease](https://scholariq.org/papers/tolvaptan-in-later-stage-autosomal-dominant-polycystic-kidney-disease/)
- [Vasopressin V <sub>2</sub> -Receptor Blockade With Tolvaptan in Patients With Chronic Heart Failure](https://scholariq.org/papers/vasopressin-v-sub-2-sub-receptor-blockade-with-tolvaptan-in-patients-with/)
- [Oral Tolvaptan Is Safe and Effective in Chronic Hyponatremia](https://scholariq.org/papers/oral-tolvaptan-is-safe-and-effective-in-chronic-hyponatremia/)
- [Prevalence of autosomal dominant polycystic kidney disease in the European Union](https://scholariq.org/papers/prevalence-of-autosomal-dominant-polycystic-kidney-disease-in-the-european-union/)
- [Clinical Pattern of Tolvaptan-Associated Liver Injury in Subjects with Autosomal Dominant Polycystic Kidney Disease: Analysis of Clinical Trials Database](https://scholariq.org/papers/clinical-pattern-of-tolvaptan-associated-liver-injury-in-subjects-with-autosomal/)
- [Efficacy and safety of oral tolvaptan therapy in patients with the syndrome of inappropriate antidiuretic hormone secretion](https://scholariq.org/papers/efficacy-and-safety-of-oral-tolvaptan-therapy-in-patients-with-the-syndrome-of/)
- [Multicenter, open-label, extension trial to evaluate the long-term efficacy and safety of early versus delayed treatment with tolvaptan in autosomal dominant polycystic kidney disease: the TEMPO 4:4 Trial](https://scholariq.org/papers/multicenter-open-label-extension-trial-to-evaluate-the-long-term-efficacy-and/)
- [Cilostazol as a Unique Antithrombotic Agent](https://scholariq.org/papers/cilostazol-as-a-unique-antithrombotic-agent/)

## University researchers

- [Frank S. Czerwiec](https://scholariq.org/researchers/frank-s-czerwiec/)

## University top topics

Showing 8 of 23.

- [Experimental Learning in Engineering](https://scholariq.org/topics/experimental-learning-in-engineering/)
- [Market Dynamics and Volatility](https://scholariq.org/topics/market-dynamics-and-volatility/)
- [Palliative Care and End-of-Life Issues](https://scholariq.org/topics/palliative-care-and-end-of-life-issues/)
- [Cardiac Arrest and Resuscitation](https://scholariq.org/topics/cardiac-arrest-and-resuscitation/)
- [Financial Markets and Investment Strategies](https://scholariq.org/topics/financial-markets-and-investment-strategies/)
- [Fish Ecology and Management Studies](https://scholariq.org/topics/fish-ecology-and-management-studies/)
- [Engineering Education and Curriculum Development](https://scholariq.org/topics/engineering-education-and-curriculum-development/)
- [Child and Adolescent Psychosocial and Emotional Development](https://scholariq.org/topics/child-and-adolescent-psychosocial-and-emotional-development/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.